Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib

Lancet

Volumn 357, Issue 9272, 2001, Pages 1946-1947

  Rocha, Jose L ^a   Fernández Alonso, Jorge ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ENALAPRIL; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; ROFECOXIB;

ACUTE DISEASE; ACUTE KIDNEY FAILURE; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HEMODIALYSIS; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FUNCTION; LABORATORY TEST; NEPHROTOXICITY; PAIN; PRIORITY JOURNAL;

EID: 0035897897     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)05083-2     Document Type: Article

References (5)

1. Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition
2. Significant upper gastrointestinal events associated with conventional NSAID versus celecoxib
3. Are selective COX-2 inhibitors nephrotoxic?
4. The clinical spectrum of tubulointerstitial nephritis
5. The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19087 patients in general practice in England: Cohort study